Found: 44
Select item for more details and to access through your institution.
Issue Highlights.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 3, doi. 10.1111/bcp.15228
- Publication type:
- Article
Anthony Peck (1933–2021).
- Published in:
- 2022
- By:
- Publication type:
- Obituary
Introduction to a series of Pro/Con papers in Clinical Toxicology.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 56, doi. 10.1111/bcp.15128
- By:
- Publication type:
- Article
Physostigmine should be used more readily for antimuscarinic toxicity: CON.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 61, doi. 10.1111/bcp.15121
- Publication type:
- Article
Physostigmine should be used more readily for antimuscarinic toxicity: PRO.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 58, doi. 10.1111/bcp.15120
- Publication type:
- Article
Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 311, doi. 10.1111/bcp.14970
- By:
- Publication type:
- Article
Health equality, race and pharmacogenomics.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 27, doi. 10.1111/bcp.14983
- By:
- Publication type:
- Article
A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 347, doi. 10.1111/bcp.14973
- By:
- Publication type:
- Article
Hospitalization for adverse events under abiraterone or enzalutamide exposure in real‐world setting: A French population‐based study on prostate cancer patients.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 336, doi. 10.1111/bcp.14972
- By:
- Publication type:
- Article
Population pharmacokinetic‐pharmacodynamic model‐based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 323, doi. 10.1111/bcp.14971
- By:
- Publication type:
- Article
Ethics in clinical pharmacology: Facilitating public trust.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 5, doi. 10.1111/bcp.15118
- By:
- Publication type:
- Article
Dose equivalence between metaraminol and norepinephrine in critical care.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 303, doi. 10.1111/bcp.14969
- By:
- Publication type:
- Article
Ethical aspects of facilitating the recruitment of people with dementia for clinical trials: A call for further debate.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 22, doi. 10.1111/bcp.14968
- Publication type:
- Article
Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 64, doi. 10.1111/bcp.14964
- By:
- Publication type:
- Article
A population physiologically‐based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 290, doi. 10.1111/bcp.14963
- By:
- Publication type:
- Article
Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real‐world vs. clinical‐trial evidence.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 282, doi. 10.1111/bcp.14961
- By:
- Publication type:
- Article
Mirtazapine use may increase the risk of hypothyroxinaemia in patients affected by major depressive disorder.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 214, doi. 10.1111/bcp.14949
- By:
- Publication type:
- Article
Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 260, doi. 10.1111/bcp.14956
- By:
- Publication type:
- Article
Model‐informed precision dosing for alemtuzumab in paediatric and young adult patients undergoing allogeneic haematopoietic cell transplantation.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 248, doi. 10.1111/bcp.14955
- By:
- Publication type:
- Article
Precision medicine and theranostics using radiopharmaceuticals in oncology.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 359, doi. 10.1111/bcp.14942
- By:
- Publication type:
- Article
The CredibleMeds<sup>®</sup> list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing information.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 226, doi. 10.1111/bcp.14951
- By:
- Publication type:
- Article
Prediction of maternal and fetal pharmacokinetics of indomethacin in pregnancy.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 271, doi. 10.1111/bcp.14960
- By:
- Publication type:
- Article
Implementing a specialist paediatric clinical pharmacology service in a UK children's hospital.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 206, doi. 10.1111/bcp.14944
- By:
- Publication type:
- Article
Evaluation of the pharmacokinetics of pemigatinib in patients with impaired hepatic or renal function.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 237, doi. 10.1111/bcp.14954
- By:
- Publication type:
- Article
Comment on "The effectiveness and safety of topical beta‐receptor blocker in treating superficial infantile haemangiomas: A meta‐analysis including 20 studies".
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 358, doi. 10.1111/bcp.14941
- By:
- Publication type:
- Article
Levetiracetam in lactation: How much is excreted into human breast milk?
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 199, doi. 10.1111/bcp.14940
- By:
- Publication type:
- Article
Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 187, doi. 10.1111/bcp.14939
- By:
- Publication type:
- Article
The association between increasing oral anticoagulant prescribing and atrial fibrillation related stroke in Ireland.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 178, doi. 10.1111/bcp.14938
- By:
- Publication type:
- Article
Relevance of primary lesion location, tumour heterogeneity and genetic mutation demonstrated through tumour growth inhibition and overall survival modelling in metastatic colorectal cancer.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 166, doi. 10.1111/bcp.14937
- By:
- Publication type:
- Article
First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 103, doi. 10.1111/bcp.14931
- By:
- Publication type:
- Article
Comparison of effectiveness and safety between ticagrelor and clopidogrel in patients with acute coronary syndrome and on dialysis in Taiwan.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 145, doi. 10.1111/bcp.14935
- By:
- Publication type:
- Article
Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 138, doi. 10.1111/bcp.14934
- By:
- Publication type:
- Article
Concentration‐QT modelling of the novel DHFR inhibitor P218 in healthy male volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 128, doi. 10.1111/bcp.14933
- By:
- Publication type:
- Article
Corticosteroid use, myocardial injury and in‐hospital cardiovascular events in patients with community‐acquired pneumonia.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 155, doi. 10.1111/bcp.14936
- By:
- Publication type:
- Article
Ethical issues in therapeutic use and research in pregnant and breastfeeding women.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 7, doi. 10.1111/bcp.14914
- By:
- Publication type:
- Article
Vitamin B12 inactivation may not be the only cause of acquired peripheral neuropathy in chronic nitrous oxide users.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 356, doi. 10.1111/bcp.14930
- By:
- Publication type:
- Article
Pharmacokinetics of capmatinib in participants with hepatic impairment: A phase 1, open‐label, single‐dose, parallel‐group study.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 91, doi. 10.1111/bcp.14929
- By:
- Publication type:
- Article
The impact of rifampicin on the pharmacokinetics of fuzuloparib in healthy Chinese male volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 84, doi. 10.1111/bcp.14926
- By:
- Publication type:
- Article
Test‐dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non‐malignant disorders.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 115, doi. 10.1111/bcp.14932
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 1, doi. 10.1111/bcp.14900
- Publication type:
- Article
Rethinking the role of Research Ethics Committees in the light of Regulation (EU) No 536/2014 on clinical trials and the COVID‐19 pandemic.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 40, doi. 10.1111/bcp.14871
- By:
- Publication type:
- Article
Promoting diseases to promote drugs: The role of the pharmaceutical industry in fostering good and bad medicalization.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 34, doi. 10.1111/bcp.14835
- Publication type:
- Article
Tacrolimus variability score outperforms coefficient of variation in predicting clinical outcomes of living kidney transplantation.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 75, doi. 10.1111/bcp.14876
- By:
- Publication type:
- Article
Ethics of vaccination: Should capability measures be used to inform SARS‐CoV‐2 vaccination strategies?
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 47, doi. 10.1111/bcp.14875
- By:
- Publication type:
- Article